198 related articles for article (PubMed ID: 22273851)
61. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
[TBL] [Abstract][Full Text] [Related]
62. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.
Bhat GA; Shah IA; Makhdoomi MA; Iqbal B; Rafiq R; Nabi S; Masood A; Lone MM; Dar NA
Tumour Biol; 2014 Jun; 35(6):5323-30. PubMed ID: 24504680
[TBL] [Abstract][Full Text] [Related]
63. Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of head and neck squamous cell carcinoma.
Han J; Wang L; Yang Y; Zhang J
Oncol Res Treat; 2014; 37(7-8):406-11. PubMed ID: 25138301
[TBL] [Abstract][Full Text] [Related]
64. CYP1A1 gene polymorphism and polycystic ovary syndrome.
Esinler I; Aktas D; Otegen U; Alikasifoglu M; Yarali H; Tuncbilek E
Reprod Biomed Online; 2008 Mar; 16(3):356-60. PubMed ID: 18339256
[TBL] [Abstract][Full Text] [Related]
65. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.
Huo D; Kim HJ; Adebamowo CA; Ogundiran TO; Akang EE; Campbell O; Adenipekun A; Niu Q; Sveen L; Fackenthal JD; Fackenthal DL; Das S; Cox N; Di Rienzo A; Olopade OI
Breast Cancer Res Treat; 2008 Jul; 110(2):367-76. PubMed ID: 17909964
[TBL] [Abstract][Full Text] [Related]
66. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
[TBL] [Abstract][Full Text] [Related]
67. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
San Jose C; Cabanillas A; Benitez J; Carrillo JA; Jimenez M; Gervasini G
BMC Cancer; 2010 Aug; 10():463. PubMed ID: 20804547
[TBL] [Abstract][Full Text] [Related]
68. Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
Mori S; Terada K; Ueki Y
Mod Rheumatol; 2012 Aug; 22(4):515-23. PubMed ID: 21993917
[TBL] [Abstract][Full Text] [Related]
69. Polymorphic variants of UGT1A1 in neonatal jaundice in southern Brazil.
Carvalho CG; Castro SM; Santin AP; de Azevedo LA; Pereira ML; Giugliani R
J Trop Pediatr; 2010 Oct; 56(5):366-7. PubMed ID: 20061399
[TBL] [Abstract][Full Text] [Related]
70. Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men.
Souiden Y; Mahdouani M; Chaieb K; Bakhrouf A; Mahdouani K
Genet Test Mol Biomarkers; 2012 Jul; 16(7):661-6. PubMed ID: 22304463
[TBL] [Abstract][Full Text] [Related]
71. UGT1A1*28 polymorphism in chronic lymphocytic leukemia: the first investigation of the polymorphism in disease susceptibility and its specific cytogenetic abnormalities.
Karakosta M; Kalotychou V; Kostakis A; Pantelias G; Rombos I; Kouraklis G; Manola KN
Acta Haematol; 2014; 132(1):59-67. PubMed ID: 24458221
[TBL] [Abstract][Full Text] [Related]
72. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.
Huang CS; Shen CY; Chang KJ; Hsu SM; Chern HD
Br J Cancer; 1999 Aug; 80(11):1838-43. PubMed ID: 10468307
[TBL] [Abstract][Full Text] [Related]
73. Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women.
Tsezou A; Tzetis M; Giannatou E; Gennatas C; Pampanos A; Kanavakis E; Kitsiou-Tzeli S
Genet Test; 2007; 11(3):303-6. PubMed ID: 17949292
[TBL] [Abstract][Full Text] [Related]
74. CYP1A1 polymorphism in adolescents with polycystic ovary syndrome.
Akgül S; Derman O; Alikaşifoğlu M; Aktaş D
Int J Gynaecol Obstet; 2011 Jan; 112(1):8-10. PubMed ID: 20965504
[TBL] [Abstract][Full Text] [Related]
75. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
76. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
[TBL] [Abstract][Full Text] [Related]
77. Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk.
Terry KL; Titus-Ernstoff L; Garner EO; Vitonis AF; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):187-90. PubMed ID: 12646505
[TBL] [Abstract][Full Text] [Related]
78. Rad51C: a novel suppressor gene modulates the risk of head and neck cancer.
Gresner P; Gromadzinska J; Twardowska E; Rydzynski K; Wasowicz W
Mutat Res; 2014 Apr; 762():47-54. PubMed ID: 24631219
[TBL] [Abstract][Full Text] [Related]
79. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract][Full Text] [Related]
80. Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls.
Zhuo X; Zhao H; Chang A; Ye H; Zhou Y; Song Y; Tan Y
Tumour Biol; 2012 Dec; 33(6):2079-89. PubMed ID: 22847262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
